Deep Origin is a biotechnology company focused on accelerating drug discovery through AI-powered tools.
The company integrates advanced computational methods with experimental data to model biological systems at scale.
The role is for a Data Scientist with expertise in quantitative pharmacokinetics, parameter estimation, and metabolic modeling.
The candidate will develop hybrid computational frameworks that combine ordinary differential equation-based (ODE-based) simulations with machine learning methods.
Responsibilities include predicting metabolic parameters, distribution profiles, and biotransformation outcomes.
This position requires strong mathematical modeling skills, statistical acumen, and experience in integrating diverse datasets into robust predictive models.
The role combines expertise in systems pharmacology, machine learning, and data-driven modeling to develop hybrid approaches for Deep Originβs AI-powered metabolism and pharmacokinetic simulation platform.
Requirements:
A PhD (0-2 years) or MS (2-5 years) in Systems Biology, Computational Pharmacology, Applied Mathematics, or a related field is required.
A strong background in ODE/PDE modeling, numerical simulation, and parameter estimation is necessary.
Experience with pharmacokinetic model development is essential.
Proficiency in Python is required.
A basic understanding of drug metabolism and pharmacokinetics (DMPK) concepts is needed.
Strong statistical analysis skills and experience with Bayesian or frequentist inference methods are required.
The ability to critically analyze data and translate findings into actionable predictions and computational models is necessary.
A collaborative mindset and comfort in both autonomous and team-based settings are important.
Adaptability to thrive in a fast-paced, deadline-driven environment is required.
Benefits:
The opportunity to work on impactful problems at the intersection of AI, chemistry, and biology.
Collaboration with multidisciplinary teams of scientists is encouraged.
The chance to shape next-generation tools for predictive drug discovery is offered.